Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(0)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Downgrades: Sell | 40 10 | 17.45 | -42.69% | 14 | Jun 25, 2025 | |
LYEL Lyell Immunopharma | Maintains: Neutral | 1 10 | 9.31 | 7.41% | 13 | Jun 24, 2025 | |
VERV Verve Therapeutics | Downgrades: Neutral | 14 14 | 11.19 | 20.64% | 7 | Jun 18, 2025 | |
NTLA Intellia Therapeutic... | Reiterates: Buy | 30 30 | 9.58 | 213.15% | 4 | Jun 16, 2025 | |
TIL Instil Bio | Reiterates: Buy | 125 125 | 27.2 | 359.56% | 17 | Jun 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 1.06 | 371.7% | 1 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 15 | 4.72 | 217.8% | 1 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 72 72 | 52.27 | 37.75% | 36 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 5 | 3.09 | 61.81% | 7 | May 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 2.25 | 122.22% | 10 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 65 65 | 47.71 | 36.24% | 3 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 50 50 | 40.02 | 24.94% | 3 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 23 15 | 4.26 | 252.11% | 8 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 45 | 16.88 | 166.59% | 15 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 115 100 | 12 | 733.33% | 12 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 14 14 | 2.94 | 376.19% | 12 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 3 | 2.19 | 36.99% | 1 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 33.42 | 124.42% | 37 | Apr 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 10.8 | 270.37% | 17 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 20 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 7 | 1.58 | 343.04% | 9 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 5 3 | 1.18 | 154.24% | 6 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 2 | 0.57 | 250.88% | 16 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 9 | n/a | n/a | 15 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 9.64 | 211.2% | 19 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 5.96 | 151.68% | 2 | Mar 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 44 44 | 21.27 | 106.86% | 13 | Feb 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | n/a | n/a | 5 | Feb 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 12 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 112 48 | n/a | n/a | 3 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 4 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 40000 610000 | 1.6 | 38124900% | 2 | Sep 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 36 | n/a | n/a | 4 | Nov 22, 2022 |